Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Role of neutralizing antibodies in controlling simian foamy virus transmission and infection.

Williams DK, Khan AS.

Transfusion. 2010 Jan;50(1):200-7. doi: 10.1111/j.1537-2995.2009.02372.x. Epub 2009 Aug 28.

PMID:
19719470
2.

Simian foamy virus infection in humans: prevalence and management.

Khan AS.

Expert Rev Anti Infect Ther. 2009 Jun;7(5):569-80. doi: 10.1586/eri.09.39. Review.

PMID:
19485797
3.

Human infection with foamy viruses.

Heneine W, Schweizer M, Sandstrom P, Folks T.

Curr Top Microbiol Immunol. 2003;277:181-96. Review.

PMID:
12908773
4.

Foamy viruses.

Neumann-Haefelin D, Fleps U, Renne R, Schweizer M.

Intervirology. 1993;35(1-4):196-207. Review.

PMID:
8407246
5.

Origin, evolution and innate immune control of simian foamy viruses in humans.

Rua R, Gessain A.

Curr Opin Virol. 2015 Feb;10:47-55. doi: 10.1016/j.coviro.2014.12.003. Epub 2015 Feb 17. Review.

PMID:
25698621
6.
7.

Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission.

Kehl T, Tan J, Materniak M.

Viruses. 2013 Sep 13;5(9):2169-209. doi: 10.3390/v5092169. Review.

8.

Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics.

Gupta S, Devanarayan V, Finco D, Gunn GR 3rd, Kirshner S, Richards S, Rup B, Song A, Subramanyam M.

J Pharm Biomed Anal. 2011 Jul 15;55(5):878-88. doi: 10.1016/j.jpba.2011.03.038. Epub 2011 Apr 6. Review.

PMID:
21531522
9.

Historical perspective of foamy virus epidemiology and infection.

Meiering CD, Linial ML.

Clin Microbiol Rev. 2001 Jan;14(1):165-76. Review.

Supplemental Content

Support Center